Guidelines on the investigation and management of antiphospholipid syndrome

Deepa J Arachchillage^{1

2}, Sean Platton³, Kieron Hickey⁴, Justin Chu⁵, Matthew Pickering^{2

6}, Peter Sommerville⁷, Peter MacCallum^{8

9}, Karen Breen¹⁰; BSH Committee

Affiliations

¹ Department of Haematology, Imperial College Healthcare NHS Trust, London, UK.
² Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
³ The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, UK.
⁴ Sheffield Laboratory Medicine, Department of Coagulation, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁵ Department of Obstetrics and Gynaecology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
⁶ Department of Rheumatology, Imperial College Healthcare NHS Trust, London, UK.
⁷ Department of Stroke Medicine, Guy's & St. Thomas' NHS Foundation Trust, London, UK.
⁸ Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
⁹ Department of Clinical Haematology, Barts Health NHS Trust, London, UK.
¹⁰ Department of Haematology, Guy's & St. Thomas' NHS Foundation Trust, London, UK.

Deepa J Arachchillage et al. Br J Haematol. 2024 Sep.

. 2024 Sep;205(3):855-880.

doi: 10.1111/bjh.19635. Epub 2024 Jul 19.

Deepa J Arachchillage^{1

2}, Sean Platton³, Kieron Hickey⁴, Justin Chu⁵, Matthew Pickering^{2

6}, Peter Sommerville⁷, Peter MacCallum^{8

9}, Karen Breen¹⁰; BSH Committee

¹ Department of Haematology, Imperial College Healthcare NHS Trust, London, UK.
² Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
³ The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, UK.
⁴ Sheffield Laboratory Medicine, Department of Coagulation, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁵ Department of Obstetrics and Gynaecology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
⁶ Department of Rheumatology, Imperial College Healthcare NHS Trust, London, UK.
⁷ Department of Stroke Medicine, Guy's & St. Thomas' NHS Foundation Trust, London, UK.
⁸ Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
⁹ Department of Clinical Haematology, Barts Health NHS Trust, London, UK.
¹⁰ Department of Haematology, Guy's & St. Thomas' NHS Foundation Trust, London, UK.

No abstract available

Keywords: anticoagulation; antiphospholipid antibodies; anti‐platelet treatment; obstetric complications; thrombocytopenia; thrombosis.

References

1. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157(1):47–58.
1. Arachchillage DRJ, Gomez K, Alikhan R, Anderson JAM, Lester W, Laffan M. Addendum to British Society for Haematology guidelines on investigation and management of antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47–58): use of direct acting oral anticoagulants. Br J Haematol. 2020;189(2):212–215.
1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
1. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023;75(10):1687–1702.
1. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7(6):330–339.